Dave Harris
Managing Director @ Pandemic Impact Fund
Denver, United States
Dave Harris is a seed investor at Pandemic Impact Fund in Denver focused on Medical and Software. Dave Harris is the Director of Operations for Rockies Venture Club (RVC), the longest running angel investor group in the US. Rockies Venture Club a non-profit organization furthering economic development in Colorado by connecting investors and entrepreneurs through conferences (Angel Capital Summit, Colorado Capital Conference, and CannabisCapital Summit), networking events, educational offerings and facilitation of Colorado’s largest angel investor groups.Prior to joining RVC, Dave worked as a collaborative start-up consultant specializing in strategy, business development, and project management. He also has 7+ years experience in international finance and content management at Thomson Reuters and Lipper, covering the financial markets for Latin America, Europe, and Canada.Dave is a graduate of the University of Colorado at Boulder, and he enjoys climbing 14ers, backpacking, fishing, and cooking; often all simultaneously, while still answering RVC emails.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Dave Harris invests in
Stages Dave Harris invests in
Countries Dave Harris invests in
Investment Focus
Industry
- Medical 2 (33%)
- Software 2 (33%)
- Health Care 2 (33%)
- Medical Device 2 (33%)
- Skiing 1 (17%)
Stage
- Seed 4 (67%)
- Series A 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
OnlySky
|
Only Sky provides a white-label, customizable platform where ski area guests craft their ideal experience on the ski area's website. Ski area staff can manage all inventory, eCommerce, POS commerce, ski school, and events from the same platform. No upfront fees and great ease of use make it an obvious choice for independent ski areas in NorthAmerica, and snow schools around the world. | $256.7K / Seed / Dec 17, 2021 | |
Vartega
|
Vartega is a technology development company specializing in the carbon-fiber-reinforced plastic recycling process. Vartega develops alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass-market applications.Vartega's patented carbon fiber recycling process scales rapidly to fill a gap in thecomposites supply chain. The company’s carbon fiber is available in semi-continuous, chopped, and milled forms. It is ideally suited for use in thermoplastics, non-wovens, and molding compounds. | Seed / Dec 01, 2021 | |
|
Vartega
|
Vartega is a technology development company specializing in the carbon-fiber-reinforced plastic recycling process. Vartega develops alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass-market applications.Vartega's patented carbon fiber recycling process scales rapidly to fill a gap in thecomposites supply chain. The company’s carbon fiber is available in semi-continuous, chopped, and milled forms. It is ideally suited for use in thermoplastics, non-wovens, and molding compounds. | Seed / Dec 01, 2021 | |
Allotrope Medical
|
Allotrope Medical is a Houston-based medical device company. Allotrope Medical’s first device, the StimSite, is an intuitive hand-held device that assists surgeons in quickly and easily identifying ureters during a surgical procedure. | $4M / Series A / Jun 01, 2021 | |
TalentBloom Healthcare
|
We have developed an interview platform that empowers interviewers to deliver a more equitable, ethical, and effective candidate experience, with a few simple clicks of the mouse. Post-pandemic and in the midst of social change, companies cannot afford to continue with the status quo of interviewing. Job seekers are demanding better, and companieshave a short window of opportunity to hire better. Our technology provides companies with a tangible solution to bolster the Equity in their diversity, equity, and inclusion initiatives. | $2M / Seed / Apr 29, 2021 | |
Spine Align
|
Spine Align is developing a portfolio of intraoperative products that both assess and assist with corrective surgeries for spinal alignment. It develops a breakthrough, patent-pending imaging technology that enables on-demand, 3D, full-length measurements of a patient’s spine with a 95% reduction in time and an 80% reduction in radiation exposurecompared to current technologies. | $1.8M / Seed / Sep 14, 2020 |
Co-Investors
About Pandemic Impact Fund
Pandemic Impact Fund invests primarily in commercialization stage companies.
Pandemic Impact Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Dave Harris
Managing Director
|
|||
Peter Adams
Managing Partner
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Dave Harris invest in?
Dave Harris invests primarily in Medical, Software and Health Care startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Dave Harris last invest?
The most recent investment recorded for Dave Harris closed in Dec 2021. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
